AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Paincom-DT Tablet

Prescription Icon
Prescription Required

Marketer

Biochem Pharmaceutical Industries

Salt Composition

Piroxicam (20mg)

Overview Paincom-DT Tablet

ArthriPain tablets offer relief from moderate to severe pain, particularly in conditions like osteoarthritis and rheumatoid arthritis. This medication targets joint and muscle pain and inflammation. For optimal absorption and to minimize stomach upset, ArthriPain should be taken with food. Dosage and treatment length are determined by your individual needs and response. Continue taking the medication as prescribed, even if symptoms improve, until your doctor advises otherwise. Common side effects may include nausea, vomiting, headache, stomach discomfort, and dizziness. Report any persistent or worsening side effects to your physician, who can offer management strategies. Prior to use, inform your doctor about any pre-existing conditions, such as stomach ulcers, heart problems, hypertension, or liver/kidney disease. Disclose all other medications you are currently using, as interactions may occur. Pregnant or breastfeeding individuals should consult their physician before using ArthriPain.

Uses of Paincom-DT Tablet

Analgesia

Major Benefits of Paincom-DT Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Paincom-DT Tablet in water before consumption. It's recommended to take this medication with food.

Common Side effects of Paincom-DT Tablet:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Paincom-DT Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Paincom-DT Tablet in water before consumption. It's recommended to take it with food.

How Paincom-DT Tablet works:

Dolprin-T tablets are a non-steroidal anti-inflammatory medication, inhibiting the production of specific inflammatory mediators to alleviate pain and reduce swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol should not be ingested while taking Paincom-DT Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Paincom-DT tablets during gestation poses a confirmed risk to the fetus, rendering their use inadvisable. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem prescription necessary if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Paincom-DT tablets are likely incompatible. Available data from human studies indicate a potential for the medication to transfer into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Paincom-DT Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Individuals with severe kidney impairment should exercise caution when using Paincom-DT Tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Paincom-DT Tablets. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Paincom-DT Tablet :

Should you forget a Paincom-DT Tablet dose, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Paincom-DT Tablet

LabelValue
Pharmaceutical Classification Compounds derived from enolic acid
Potential for Dependence None.
Type of Medication Pain relievers

FAQs on Paincom-DT Tablet

Paincom-DT Tablets and diclofenac are analgesics. Piroxicam, a component of Paincom-DT, non-selectively inhibits cyclooxygenase (COX), an enzyme involved in pain and inflammation. Diclofenac, conversely, exhibits greater COX-2 enzyme selectivity. This enhanced selectivity in diclofenac is believed to reduce adverse reactions relative to Paincom-DT Tablets.
Naproxen and Paincom-DT Tablet are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain sensation. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects than Paincom-DT Tablet.
Paincom-DT Tablet and meloxicam are both analgesics, each inhibiting cyclooxygenase (COX), the enzyme mediating inflammation and pain perception. Clinical trials demonstrate comparable efficacy between the two. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse effects relative to Paincom-DT Tablet.
Paincom-DT tablets and ketoprofen are both nonsteroidal anti-inflammatory drugs (NSAIDs) that alleviate pain by inhibiting cyclooxygenase (COX), an enzyme involved in inflammation and pain sensation. Clinical trials indicate superior efficacy and effectiveness of topical ketoprofen gel relative to Paincom-DT tablets. Furthermore, ketoprofen gel demonstrated excellent patient tolerability.
Paincom-DT tablets target cyclooxygenase, an enzyme contributing to inflammation and pain, while Tramadol acts as a centrally-acting analgesic with opioid-like properties. Tramadol carries a risk of dependence.
Paincom-DT tablets and nimesulide are analgesics. Paincom-DT tablets non-selectively inhibit COX enzymes (cyclooxygenase, implicated in pain and inflammation), unlike nimesulide, which exhibits COX-2 selectivity. This selectivity in nimesulide is believed to reduce adverse effects relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam may increase the risk of bleeding. Therefore, avoid taking Paincom-DT Tablet or other pain relievers if you experience fever and joint pain. Seek medical advice before using Paincom-DT Tablet.
Paincom-DT tablets and aspirin are distinct medications, though both are classified as COX (cyclooxygenase) inhibitors. Both drugs exhibit anti-inflammatory and analgesic properties.
Concurrent use of Paincom-DT tablets and dexamethasone is contraindicated due to their synergistic toxicity, significantly elevating the risk of gastrointestinal ulceration.
Concurrent use of methocarbamol and Paincom-DT tablets is considered safe, lacking known significant adverse interactions. Physician consultation is advised prior to initiating either treatment.
Confirmation: Concurrent use of paracetamol and Paincom-DT tablets is acceptable, as significant adverse reactions are undocumented. However, physician consultation is advised prior to initiating either treatment.
Paincom-DT Tablet is classified as a non-steroidal anti-inflammatory drug; yes.
Sulphur-based Paincom-DT tablets may induce serious side effects in susceptible patients, including potentially life-threatening dermatological reactions such as Stevens-Johnson syndrome. Patients with allergies should disclose this information to their physician.
Paincom-DT Tablets do not possess anticoagulant properties; they are analgesics. Their use is contraindicated in individuals with hemorrhagic conditions.
Paincom-DT tablets do not relax muscles. They are analgesics that inhibit COX (cyclooxygenase), the enzyme mediating inflammation and pain.
Paincom-DT tablets do not contain narcotics. This analgesic reduces pain and inflammation by targeting the COX enzyme, a key player in the inflammatory process.
Paincom-DT Tablets do not treat high blood pressure. Concomitant use with antihypertensive drugs reduces their efficacy. Disclose any antihypertensive medication use to your physician prior to commencing Paincom-DT Tablet therapy.
Concurrent use of Paincom-DT Tablets and Losartan is contraindicated. Paincom-DT Tablets diminish the efficacy of antihypertensive drugs such as Losartan, potentially rendering antihypertensive treatment ineffective. Disclose any current antihypertensive medication use to your physician prior to commencing Paincom-DT Tablet therapy.
Concurrent use of Paincom-DT Tablet and lisinopril is contraindicated. Piroxicam, a component of Paincom-DT Tablet, diminishes the antihypertensive efficacy of lisinopril, potentially resulting in treatment failure. Disclose your use of antihypertensive drugs to your physician prior to commencing Paincom-DT Tablet therapy.
Paincom-DT Tablets may be administered concurrently with calcium channel blockers. Nonsteroidal anti-inflammatory drugs (NSAIDs) have demonstrated a decreased efficacy of most antihypertensive medications; however, this effect is not observed with calcium channel blockers (White, 2007).
Paincom-DT Tablets can be used concurrently with tizanidine. Piroxicam, an analgesic, and tizanidine, a muscle relaxant, are suitable for conditions such as back pain.
Paincom-DT Tablet is compatible with beta-cyclodextrin. Studies indicate this combination accelerates piroxicam's onset and mitigates gastrointestinal adverse reactions.
Affirmative. Paincom-DT Tablet has viable alternatives. Analgesic selection depends on the specific illness. A physician's consultation is necessary before commencing piroxicam therapy or switching medications.
Piroxicam should not be used in patients with allergies, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney dysfunction.
Paincom-DT Tablets are not indicated for allergy treatment; their purpose is pain relief.
Piroxicam, the active component in Paincom-DT Tablets, provides extended pain relief with a single daily dose. However, individual responses vary, and analgesic efficacy generally improves with continued use over several weeks.
Paincom-DT Tablets are not associated with hypertension. This medication is a non-opioid analgesic.
Menstrual cramps are not an approved indication for Paincom-DT Tablets. Clinical trials demonstrate that piroxicam substantially reduces the severity of menstrual pain.
Migraine is not an approved indication for Paincom-DT Tablet. Clinical trials demonstrate Paincom-DT Tablet's efficacy in substantially reducing migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's consultation is necessary to determine the underlying cause of your back pain before commencing treatment. Avoid self-treating with Paincom-DT Tablets, as the etiology of back pain varies individually.
Acute gout may be treated with Paincom-DT Tablets. Clinical trials have demonstrated Paincom-DT Tablets' significant efficacy in managing acute gout episodes.
Blood donation is permissible while taking Paincom-DT Tablets; however, it's crucial to consult your physician beforehand.
In diabetic individuals, Piroxicam, the active ingredient in Paincom-DT tablets, should be used solely under medical supervision. Prolonged use of this medication carries a significant risk of kidney failure. Since diabetes is already a risk factor for kidney disease, the addition of piroxicam substantially elevates this risk.
Paincom-DT Tablets are contraindicated in individuals with impaired kidney function. Prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with kidney damage, including papillary necrosis.
Affirmative. Paincom-DT Tablets have been associated with cutaneous adverse reactions, potentially severe, including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN)—conditions that can be life-threatening. These serious reactions may develop unexpectedly. Report any minor skin eruption to your physician and cease taking the medication immediately.
Paincom-DT tablets are contraindicated during pregnancy. Their use is associated with premature ductus arteriosus closure, potentially resulting in fetal cardiac failure and neonatal mortality.
Paincom-DT Tablets are not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and bleeding.
Individuals with asthma may experience heightened sensitivity to non-steroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Physician consultation is recommended prior to commencing treatment with these drugs.
Paincom-DT Tablets may induce temporary infertility in some cases. This effect, stemming from piroxicam's mechanism, potentially hinders or stops the release of ovarian follicles, a factor linked to reversible infertility. Seek medical advice prior to commencing treatment.
Paincom-DT Tablets are contraindicated for concurrent use with diuretics. In certain individuals, Paincom-DT Tablets diminish the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to stem from the medication's suppression of renal prostaglandin production.
Concurrent use of Paincom-DT Tablet and lithium is contraindicated. Paincom-DT Tablet elevates lithium plasma concentrations and diminishes renal lithium excretion. This effect stems from the NSAID's inhibition of renal prostaglandin production. Physician consultation is mandatory prior to commencing Paincom-DT Tablet therapy.
Concurrent use of Paincom-DT tablets and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician before taking Paincom-DT. If co-administered, close medical supervision is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional contributing factors to this increased risk.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics, either immediately preceding or following coronary artery bypass grafting (CABG).
Gastrointestinal distress, and in uncommon instances, severe gastrointestinal adverse reactions including peptic ulcers and hemorrhage; serious dermatological reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic failure; and kidney impairment.
Paincom-DT Tablet
56
MRP 68
18% off